MTOR and cancer: In comparison with the HDAC inhibitor treatment, VEGF, Vimentin, p-PI3k, p-Akt, and p-mTOR protein expression levels were significantly decreased in the cancer cells treated by HDAC inhibitor+PI3K inhibitor; while E-cadherin protein level was significantly increased (P<0.05).